Loading...
•
Jun 30, 2023
Bausch + Lomb Q2 2023 Earnings Report
Bausch + Lomb's second-quarter performance was characterized by double-digit total revenue growth across all segments, despite ongoing supply chain issues, and the advancement of plans to reshape the company.
Key Takeaways
Bausch + Lomb reported revenues of $1.035 billion, a 10% increase compared to the second quarter of 2022. The company experienced a GAAP Net Loss Attributable to Bausch + Lomb Corporation of $32 million. They raised their full-year revenue outlook and reaffirmed Adjusted EBITDA guidance range.
Revenues of $1.035 Billion
GAAP Net Loss Attributable to Bausch + Lomb Corporation of $32 Million
Adjusted EBITDA (non-GAAP) of $179 Million
Revenues Grew 10% as Reported and 12% on a Constant Currency Basis Compared to the Second Quarter of 2022, Driven by Growth Across All Segments
Bausch + Lomb
Bausch + Lomb
Bausch + Lomb Revenue by Segment
Revenue by Segment
Vision Care Revenue
CapyFin.comSurgical Revenue
CapyFin.comPharmaceuticals Revenue
CapyFin.com Forward Guidance
Bausch + Lomb raised its revenue guidance for the full year of 2023 and reaffirmed its Adjusted EBITDA (non-GAAP) guidance for the full year of 2023.
Positive Outlook
- Full-Year revenue between $3.95 - $4.00 billion
- Full-year Adjusted EBITDA (non-GAAP) between $700 - $750 million
- ~6.5 - 7.5% constant currency growth
- Foreign exchange headwinds for the full year Revenue: ~$50 million
- Foreign exchange headwinds for the full year Adj. EBITDA (non-GAAP): ~$35 million
Revenue & Expenses
Visualization of income flow from segment revenue to net income